Results 221 to 230 of about 33,126 (285)

Lactylation in cancer: Unveiling new layers of complexity. [PDF]

Innovation (Camb)
Zhang S, Xie B, Zhu X, Dong S, Li M.
europepmc   +1 more source

Acetyltransferase in cardiovascular disease and aging. [PDF]

J Cardiovasc Aging
Keller MA, Nakamura M.
europepmc   +1 more source

Interaction between ZMIZ2 and AR promotes prostate cancer proliferation in vitro and in vivo. [PDF]

Cancer Biol Ther
Yu JZ, Zou XP, Wu XB, Cui YY, Wei T, Di J, Feng XC, Li XM.   +7 more
europepmc   +1 more source

Structural and Functional Studies on Key Epigenetic Regulators in Asthma. [PDF]

Biomolecules
Fakhar M, Gul M, Li W.
europepmc   +1 more source

African swine fever virus DEAD-box helicase D1133L promotes OGG1-driven incision of genomic 8-oxoG via HDAC5 deacetylation. [PDF]

J Mol Cell Biol
Fan J, Yang J, Tian Z, Zhang X, Geng S, Luo J, Boldogh I, Zeng Q, Yin H, Guan G, Niu Q.   +10 more
europepmc   +1 more source

ArylamineN-acetyltransferases

Expert Opinion on Drug Metabolism & Toxicology, 2007
Arylamine N-acetyltransferases (NATs), known as drug- and carcinogen-metabolising enzymes, have had historic roles in cellular metabolism, carcinogenesis and pharmacogenetics, including epidemiological studies of disease susceptibility. NAT research in the past 5 years builds on that history and additionally paves the way for establishing the following
Edith, Sim, Isaac, Westwood, Elizabeth, Fullam   +2 more
openaire   +3 more sources

Regulation of Arylamine N-Acetyltransferases

Current Drug Metabolism, 2008
Acetylation catalysed by the arylamine N-acetyltransferases (NATs; 2.3.1.5) is a major biotransformation pathway for arylamine and hydrazine drugs, as well as many carcinogens that we are exposed to on a daily basis. These compounds can either be detoxified by NATs or bioactivated to metabolites that have the potential to cause toxicity such as cancer.
Butcher, Neville J., Tiang, Jacky, Minchin, Rodney F.   +2 more
openaire   +6 more sources

The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases

Cell, 1996
p300/CBP is a transcriptional adaptor that integrates signals from many sequence-specific activators via direct interactions. Various cellular and viral factors target p300/CBP to modulate transcription and/or cell cycle progression. One such factor, the
Vasily Ogryzko, R Louis Schiltz, Yoshihiro Nakatani   +2 more
exaly   +2 more sources